Bristol-Myers Squibb (BMY) to Acquire Turning Point Therapeutics (TPTX) for $76 Per Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.59 | 52 Week High | $77.12 | |||
| Open | $59.59 | 52 Week Low | $49.03 | |||
| Day High | $59.59 | P/E | 38.69 | |||
| Day Low | $59.59 | EPS | $1.54 | |||
| Volume | 2,731 | |||||
| TORREYPINES THERA (NASDAQ: TPTX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $0.69 | |||
| Open | $0.10 | 52 Week Low | $0.07 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-0.90 | |||
| Volume | 11,307 | |||||
